◆ 会议时间:2023年10月20-24日
◆ 会议地点:西班牙 马德里
◆ 会议简介:
2023年欧洲肿瘤内科学会(ESMO)年会将于2023年10月20-24日在西班牙马德里举行,会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议,每年都有超过30,000名专业人士参加会议;届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂,一起分享了解肿瘤学领域的最新进展,并将科学转化为最佳的癌症护理。ESMO大会科学计划将由一个300多名国际专家组成的委员会制定,内容涵盖从基础研究到癌症免疫治疗的最新发现,从肿瘤护理到姑息治疗,从罕见癌症到药物批准,等等。ESMO年度大会将成为转化研究、呈现实践变化数据和多学科讨论的卓越全球平台,大会将宣提供优秀的科学教育计划,传播最新的前沿数据,为来自世界各地的肿瘤学家和其他利益相关者提供高质量的教育和无与伦比的交流机会。(2022ESMO年会数字:29300余名与会者来自150多个国家/地区;1900多份摘要提交)
欧洲肿瘤内科学会(ESMO)成立于1975年,是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会,现在全球160多个国家和地区拥有超过25,000余名会员;ESMO致力于通过宣促进多学科的癌症护理,支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理,尽而为癌症患者提供最佳的护理。未经本站许可禁止复制转载摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com)。
ESMO 2023 - European Society of Medical Oncology (ESMO) Congress
Date: 20-24 October 2023
Venue: IFEMA MADRID, Madrid, Spain
The ESMO Congress is the most influential oncology platform designed in Europe for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO Congress 2023 will again present the very latest advances in the treatment of cancer and offer an excellent educational programme, with a wealth of opportunities for exchange of ideas among delegates.
进入大会虚拟平台>>>Access the Platform>>>
摘要征文投稿:
Abstract submission deadlines-征稿截止日期
Deadline |
Date and time |
Regular abstracts
常规摘要征稿截止时间 |
10 May 2023, 21:00hrs CEST
(CEST = Central European Summer Time) |
Late-breaking abstracts
LBA摘要征稿截止时间 |
14 September 2023, 21:00hrs CEST
(CEST = Central European Summer Time) |
点此提交摘要>>>Submit Abstract>>>
ESMO Congress 2023 Abstract Regulations
Outcome notifications-结果通知
Outcome notifications are expected to be made available to first authors and submitters between 19 and 21 July 2023.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by end September.
Information for presenters-演示者信息
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website in early August 2023, in the section “Information for Presenters”.
Abstract submission categories-摘要提交类别
Basic science |
NSCLC, early stage |
Biliary tract cancer, incl. cholangiocarcinoma |
NSCLC, locally advanced |
Biomarkers (agnostic) |
NSCLC, metastatic |
Breast cancer, early stage |
Oesophagogastric cancer |
Breast cancer, locally advanced |
Palliative care |
Breast cancer, metastatic |
Pancreatic cancer |
CNS tumours |
Policy and preventive strategies |
Colorectal cancer |
Prostate cancer |
Developmental therapeutics |
Psycho-oncology |
Endocrine tumours |
Renal cancer |
Germ cell (testicular) cancer and penile cancer |
Sarcoma |
Gynaecological cancers |
SCLC |
Haematological malignancies |
Supportive care |
Head and neck cancer, excluding thyroid |
Thoracic malignancies, other |
Hepatocellular carcinoma (HCC) |
Thyroid cancer |
Investigational immunotherapy |
Translational research (agnostic) |
Melanoma and other skin tumours |
*Cancer nursing: eHealth and digital innovations |
Miscellaneous |
*Cancer nursing: Health promotion, prevention and screening |
Neuroendocrine tumours |
*Cancer nursing: Supportive care |
New diagnostic tools |
*Cancer nursing: Symptom management |
NSCLC, early stage |
*Cancer nursing: Palliative and end-of-life care |
NSCLC, locally advanced |
*Cancer nursing: Workforce and educational issues in cancer nursing |
*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO Congress 2023 submission regulations and guidelines.
Late-breaking abstracts (LBA) - 最新突破性数据摘要
Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 14 September 2023 is under no circumstances to be considered as an extension of the general submission deadline.
Trial in progress abstracts (TiP)-进行中的试验摘要
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Congress 2023.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Presentation of accepted abstracts
The ESMO Congress 2023 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium - Oral presentations of cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper – Oral presentations of original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentation of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts will be published in the ESMO Congress 2023 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
ESMO2023 注册费:
Registration fees
(21% Spanish VAT included) |
Early registration
until 19 July 2023 |
Late registration
until 13 September 2023 |
Full registration
from 14 September 2023 |
ESMO Member |
€ 622.00 |
€ 875.00 |
€ 1,115.00 |
ESMO Member Developing Countries* |
€ 162.00 |
€ 260.00 |
€ 292.00 |
ESMO Member in Training** |
€ 97.00 |
€ 130.00 |
€ 195.00 |
ESMO Member Undergraduate Student |
€ 97.00 |
€ 130.00 |
€ 195.00 |
ESMO Member Nurse |
€ 520.00 |
€ 520.00 |
€ 520.00 |
ESMO Member Patient Advocate |
€ 97.00 |
€ 130.00 |
€ 195.00 |
EONS Nurse |
€ 520.00 |
€ 520.00 |
€ 520.00 |
EONS Nurse Trainee |
€ 97.00 |
€ 97.00 |
€ 97.00 |
Non-Member |
€ 970.00 |
€ 1,230.00 |
€ 1,490.00 |
On-site Daily passes - ESMO Member – no webcast |
|
|
€ 550.00 |
On-site Daily passes - Non-Member – no webcast |
|
|
€ 770.00 |
* Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO members must be under 40 and in training to qualify for this fee.
In-person participation includes:
- Admission to on-site scientific and educational sessions with the possibility to interact with Speakers, Chairs and panels.
- On-site networking opportunity with Faculty and peers
- Entry to the Poster area
- Interaction with industry partners in the trade exhibition
- Participation in the Industry Satellite Symposia
- Access to the Virtual Platform to follow sessions live and/or view content on-demand
- Post-event resources, except for On-site Daily passes
Online participation includes:
- Access to the Virtual Platform, with live streaming of all sessions
- Possibility to interact through the chat live
- Access to e-Posters
- Entry to the Virtual Exhibition
- Participation in the Industry Satellite Symposia
- Post-event resources
Other registration fees for on-site only (21% Spanish VAT included) - virtual platform not included |
Fee |
Access |
Extra exhibitor badge (for additional exhibiting company staff) |
€ 242 |
Exhibition and industry satellite area, private meeting and business rooms |
Private Meeting badge |
€ 121 |
Private meeting and business rooms only |
Exhibitor Visitor badge |
€ 121 |
Exhibition area only |
Industry Symposium badge |
€ 121 |
Industry satellite area only |
2022年ESMO年会数字播报:
ESMO2023-欧洲肿瘤年会-ESMO欧洲肿瘤内科学会2023-ESMO年会/大会-ESMO Congress 2023
◆ 参会对象:
肿瘤科医师、放射科医师,介入放射科医师,外科/普外科医师,病理科医师,护士以及从事肿瘤护理与研究的其他相关专业人士等。
|